Literature DB >> 35579737

NF-κB/ABCA1 pathway aggravates ox-LDL-induced cell pyroptosis by activation of NLRP3 inflammasomes in THP-1-derived macrophages.

Jiashan Li1,2, Jiaru Liu1,2, Ying Yu1,2, Yuee Liu1,2, Xiuru Guan3,4.   

Abstract

OBJECTIVE: NF-κB (nuclear transcription factor-kappa B) plays a well-known function in the regulation of immune responses and inflammation, but growing evidences support a major role of it in atherosclerosis. Currently, the regulatory mechanism of NF-κB pathway involved in atherosclerosis remains unclear.
METHODS: To investigate the role of ox-LDL (oxidized low-density lipoprotein) in NF-κB regulation, the protein expression of phosphorylated NF-κB, a marker of NF-κB pathway activation was measured. The pyroptosis of macrophage was evaluated by western blot and fluorescence microscope. Cholesterol efflux capacity was determined by fluorescence assay and oil red O staining. The inhibitor of activation of NF-κB signal was used to assess the effect of NF-κB signal on macrophage pyroptosis and cholesterol efflux in macrophage. Small interfering RNA of ABCA1 (cholesterol transporters ATP binding boxes A1) was used to assess the effect of ABCA1 on macrophage pyroptosis.
RESULTS: In this study, we reported THP-1 derived macrophage can be stimulated to increase pyroptosis by ox-LDL in a concentration-dependent manner. Macrophage pyroptosis was correlated with enhanced activation of NF-κB signal. After using inhibitor of NF-κB phosphorylation to attenuate activation of NF-κB signal, we identified and confirmed the decrease of macrophage pyroptosis and the occurrence of ox-LDL-induced cholesterol efflux disorder. Furthermore, we found that the downregulation of ABCA1 led to increased cell inflammation death. But pyroptosis was blocked, may led to cholesterol efflux dysfunction.
CONCLUSION: Taken together, the present results indicate that the mechanism of NF-κB involved in the development of atherosclerosis depends on mediating cell pyroptosis and cholesterol efflux and provide significant light on macrophage NF-κB signal in atherosclerosis.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  ABCA1; Atherosclerosis; Cell pyroptosis; NF-κB signal

Mesh:

Substances:

Year:  2022        PMID: 35579737     DOI: 10.1007/s11033-022-07408-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  24 in total

Review 1.  Role of pyroptosis in cardiovascular diseases.

Authors:  Chang Jia; Huanwen Chen; Jian Zhang; Kailiang Zhou; Yingzhi Zhuge; Chao Niu; Jianxin Qiu; Xing Rong; Zhewei Shi; Jian Xiao; Yong Shi; Maoping Chu
Journal:  Int Immunopharmacol       Date:  2018-12-17       Impact factor: 4.932

2.  Salidroside Decreases Atherosclerosis Plaque Formation via Inhibiting Endothelial Cell Pyroptosis.

Authors:  Sha-Sha Xing; Jin Yang; Wen-Jing Li; Jian Li; Lin Chen; Yu-Ting Yang; Xia Lei; Jun Li; Kai Wang; Xun Liu
Journal:  Inflammation       Date:  2020-04       Impact factor: 4.092

3.  Melatonin protects embryonic development and maintains sleep/wake behaviors from the deleterious effects of fluorene-9-bisphenol in zebrafish (Danio rerio).

Authors:  Ping Mi; Qiu-Ping Zhang; Shi-Bao Li; Xing-Yu Liu; Shu-Hui Zhang; Meng Li; Dong-Yan Chen; Xin Zhao; Dao-Fu Feng; Xi-Zeng Feng
Journal:  J Pineal Res       Date:  2018-10-22       Impact factor: 13.007

4.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Authors:  Paul M Ridker; Brendan M Everett; Tom Thuren; Jean G MacFadyen; William H Chang; Christie Ballantyne; Francisco Fonseca; Jose Nicolau; Wolfgang Koenig; Stefan D Anker; John J P Kastelein; Jan H Cornel; Prem Pais; Daniel Pella; Jacques Genest; Renata Cifkova; Alberto Lorenzatti; Tamas Forster; Zhanna Kobalava; Luminita Vida-Simiti; Marcus Flather; Hiroaki Shimokawa; Hisao Ogawa; Mikael Dellborg; Paulo R F Rossi; Roland P T Troquay; Peter Libby; Robert J Glynn
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

Review 5.  Pyroptosis and its relationship to atherosclerosis.

Authors:  Yuan-Jun Xu; Lei Zheng; Yan-Wei Hu; Qian Wang
Journal:  Clin Chim Acta       Date:  2017-11-10       Impact factor: 3.786

6.  FGF21 mitigates atherosclerosis via inhibition of NLRP3 inflammasome-mediated vascular endothelial cells pyroptosis.

Authors:  Zhaolin Zeng; Qiuping Zheng; Jiaojiao Chen; Xianhua Tan; Qiang Li; Lingxin Ding; Ren Zhang; Xiaolong Lin
Journal:  Exp Cell Res       Date:  2020-05-20       Impact factor: 3.905

7.  Targeting HDAC6 attenuates nicotine-induced macrophage pyroptosis via NF-κB/NLRP3 pathway.

Authors:  Shuang Xu; Hangwei Chen; Huaner Ni; Qiuyan Dai
Journal:  Atherosclerosis       Date:  2020-11-24       Impact factor: 5.162

8.  Proteomic analysis reveals that Xbp1s promotes hypoxic pulmonary hypertension through the p-JNK MAPK pathway.

Authors:  Hongxia Jiang; Yang Niu; Yuanzhou He; Xiaochen Li; Yongjian Xu; Xiansheng Liu
Journal:  J Cell Physiol       Date:  2021-12-28       Impact factor: 6.384

9.  RAV transcription factors are essential for disease resistance against cassava bacterial blight via activation of melatonin biosynthesis genes.

Authors:  Yunxie Wei; Yanli Chang; Hongqiu Zeng; Guoyin Liu; Chaozu He; Haitao Shi
Journal:  J Pineal Res       Date:  2017-12-04       Impact factor: 13.007

10.  Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores.

Authors:  Xing Liu; Zhibin Zhang; Jianbin Ruan; Youdong Pan; Venkat Giri Magupalli; Hao Wu; Judy Lieberman
Journal:  Nature       Date:  2016-07-07       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.